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Background: Emerging evidence indicates that there is an association between vitamin D and obesity. The aim of
this study was to investigate whether the level of serum 25-hydroxyvitamin D3 [25(OH)D3] in the elderly is
influenced by parameters of anthropometry and body composition independent of potential confounding lifestyle
factors and the level of serum intact parathyroid hormone (iPTH).
Methods: Cross-sectional data of 131 independently living participants (90 women, 41 men; aged 66–96 years) of
the longitudinal study on nutrition and health status in senior citizens of Giessen, Germany were analysed.
Concentrations of 25(OH)D3 and iPTH were ascertained by an electrochemiluminescence immunoassay. Body
composition was measured by a bioelectrical impedance analysis. We performed univariate and multiple regression
analyses to examine the influence of body composition on 25(OH)D3 with adjustments for age, iPTH and lifestyle
factors.
Results: In univariate regression analyses, 25(OH)D3 was associated with body mass index (BMI), hip circumference
and total body fat (TBF) in women, but not in men. Using multiple regression analyses, TBF was shown to be a
negative predictor of 25(OH)D3 levels in women even after controlling for age, lifestyle and iPTH (ß=−0.247;
P= 0.016), whereas the associations between BMI, hip circumference and 25(OH)D3 lost statistical significance after
adjusting for iPTH. In men, 25(OH)D3 was not affected by anthropometric or body composition variables.
Conclusions: The results indicate that 25(OH)D3 levels are affected by TBF, especially in elderly women,
independent of lifestyle factors and iPTH.
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There is emerging evidence that, in addition to its well-
established role in the regulation of calcium homeostasis
and bone metabolism, vitamin D has multiple functions
in human health. Accumulating epidemiological data in-
dicate that a low vitamin D status is linked to a variety
of chronic diseases that are associated with aging, in-
cluding cancer, autoimmune diseases, hypertension and
diabetes mellitus [1-3]. Elderly people are especially at
risk for a vitamin D deficiency because of age-related
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reproduction in any medium, provided the orexposure and dietary intake [4]. It is a moot point
whether adiposity, which is increasingly prevalent in
people with advanced age [5], may also negatively impact
the vitamin D status in the elderly. Numerous studies
have linked low 25-hydroxyvitamin D levels [25(OH)D],
the commonly used indicator of the vitamin D status
[6], with obesity [7-21], whereas other researchers have
failed to confirm this observation [22-24]. There are
some limitations of these previous studies. First, these
studies often included only women, vitamin D-deficient
individuals, ambulatory patients, morbidly obese subjects
or subjects of young or middle age, and the interpret-
ation of these results is limited, especially in reference to
elderly individuals. Second, the majority of these studies
relied on body mass index (BMI) without a furtherl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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these studies did not control for potential confounders,
such as age, nutrient intake, use of vitamin D supple-
ments, daily sun exposure, physical activity and smoking,
which may be associated with both vitamin D status and
adiposity. In this context, intact parathyroid hormone
(iPTH) is also expected to be a relevant confounder or
even the causal factor of the association between TBF and
25(OH)D [25], and previous studies often concentrated
exclusively on 25(OH)D or iPTH without considering the
interaction between both. Fourth, anthropometric and
body composition variables were frequently included sim-
ultaneously in the multiple regression model. Conse-
quently, these results must be interpreted with caution.
Overall, studies in which the associations of anthro-
pometry and body composition with 25(OH)D were
examined in predominantly non-obese, well-functioning
elderly women and men are scarce. Therefore, and in
view of the inconsistent results and the above mentioned
limitations of previous studies, the primary objective of
our study was to analyse whether anthropometric char-
acteristics and body composition contribute to the 25-
hydroxyvitamin D3 [25(OH)D3] status in non-
institutionalised, primarily non-obese elderly women and
men. In this context, potential confounders of this asso-
ciation, such as age, sun exposure, physical activity, vita-
min D and calcium intake, smoking history, alcohol
consumption and iPTH, were considered. In this way,
we could scrutinise whether anthropometric and body
composition variables are independent predictors for 25
(OH)D3 levels in the elderly or whether age, lifestyle or
iPTH may account for the effects of body composition
on the 25(OH)D3 status.
Methods
Subjects
Subjects were participants of the GISELA study, a pro-
spective cohort study in which the nutrition and health
status of senior citizens from Giessen (50°35′North),
Germany, have been observed since 1994. All investiga-
tions took place in the Institute of Nutritional Science in
Giessen from July to October. For enrolment, subjects
had to be at least 60 years of age and able to visit the in-
stitute without assistance. A written informed consent
was obtained from each participant. The study protocol
was approved by the Ethical Committee of the Faculty of
Medicine at the Justus-Liebig-University, Giessen.
The present investigation reports cross-sectional data
from the GISELA study obtained in 2008. Subjects with
incomplete data were excluded. Those individuals who
took diuretics, had undergone a hormone replacement
therapy or suffered from chronic kidney disease or
oedema were also excluded from the analysis. Eight
people were characterised as outliers due to their serum25(OH)D3 and iPTH measurements as well as the resi-
duals of the regression analyses and were therefore not
included. Of the 275 elderly people who took part in the
follow-up in 2008, data from 90 women and 41 men
were included in the following analysis.
Anthropometric data and body composition
Body weight was determined by a calibrated digital scale
(Seca, Vogel & Halke, Hamburg, Germany) to the nearest
0.1 kg in light clothes without shoes. Based on the weight
of the remaining clothes, 0.5 to 1.0 kg was subtracted from
the measured weight. Body height was recorded standing
upright without shoes via a telescopic rod integrated in
the scale to the nearest 0.5 cm. The BMI categories were
established such that subjects with a BMI< 25.0 kg/m²
were classified as normal weight, whereas participants
with a BMI≥ 25.0 kg/m² were defined as overweight to
obese. The waist-to-hip ratio (WHR) and waist circumfer-
ence (WC) were used as markers for body fat distribution.
Abdominal obesity was defined according to the WHO
[26] as a WHR> 0.85 for women and> 1.0 for men or a
WC≥ 88 cm for women and≥ 102 cm for men. The WC
and hip circumference (HC) were determined in an up-
right position by a tape measure to the nearest 1.0 cm.
Body composition was recorded by a single-frequency
(50 kHz) bioelectrical impedance analyser (Akern-RJL
BIA 101/S, Data Input, Frankfurt, Germany) according
to the instructions of the manufacturer and the predict-
ive formula from Roubenoff et al. [27].
Laboratory measurements
Blood samples for serum 25(OH)D3 and iPTH were col-
lected between 7:00 a.m. and 11:00 a.m. after an overnight
fast and serum aliquots were stored at −70°C until further
analysis. Both 25(OH)D3 and iPTH were measured by a
direct electrochemiluminescence immunoassay (ECLIA,
Roche Diagnostics, Mannheim, Germany) [28,29]. Import-
antly, the ECLIA specifically detects the 25(OH)D3 con-
centration. We defined 25(OH)D3< 25.0 nmol/L as
vitamin D-deficient, 25.0–49.9 nmol/L as insufficient
and≥ 50.0 nmol/L as adequate. In addition, we accounted
for the ongoing debate concerning the use of higher cut-
off values by means of an accessory cut-off value
of≥ 75.0 nmol/L [1,30].
Lifestyle factors
A three-day estimated dietary record, which was devel-
oped and validated for the GISELA study, functions to
determine the nutritional intake of each subject [31].
Smoking behaviour, current daily time spent outdoors,
physical activity pattern and further data, such as age,
diseases, medications and vitamin D supplement intake,
were collected using self-administered questionnaires.
The current time spent outdoors (min/d) was used as an
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(never-smokers vs. current and ex-smokers) and the use
of vitamin D supplements (no/yes) were coded as di-
chotomous variables. The physical activity level (PAL) of
each participant was assessed as described elsewhere
[32].
Statistical analysis
The characteristics of the study subjects were expressed
as medians and the 5th–95th percentiles due to non-
normally distributed data. Because of significant sex dif-
ferences in the amount of TBF, fat distribution and life-
style factors, we performed sex-stratified analyses.
According to the sample size, a normal distribution was
tested by the Shapiro-Wilk test for men and by the
Kolmogorov-Smirnov test with the Lilliefors correction
for women. Descriptive characteristics were compared
between groups via the Mann-Whitney U test for con-
tinuous variables and via the χ² test or, alternatively,
Fisher’s exact test for categorical variables.
Whenever subjects with an adequate vitamin D status
were compared with vitamin D-insufficient individuals, we
used two different 25(OH)D3 cut-off values (≥ 50 nmol/L
and≥ 75 nmol/L). The study cohort was split by BMI into
two groups to compare normal-weight subjects with
overweight to obese participants for the prevalence of
vitamin D insufficiency by means of the Fisher’s exact test.
In addition, we divided the cohort into subjects with
abdominal obesity and participants without an abdominal
fat distribution, as defined by the WHR and WC, and
analysed whether differences concerning the prevalence
of vitamin D insufficiency exist. Furthermore, subjects
with an adequate vitamin D status were compared with
vitamin D-insufficient individuals with regard to para-
meters of anthropometry and body composition by
using the Mann-Whitney U test.
We examined univariate associations of 25(OH)D3
with iPTH and parameters of lifestyle, anthropometry
and body composition by simple regression analyses.
Serum iPTH was regarded as a covariate because iPTH
can promote the turnover of circulating 25(OH)D3 by
inducing the formation of 1,25-dihydroxyvitamin D3
[33]. On the basis of non-normally distributed residuals,
the dependent variable 25(OH)D3 was logarithmically
transformed (log10) to obtain a normal distribution of
residuals.
Finally, we performed sex-stratified hierarchical mul-
tiple regression analyses. In detail, we created three
models with different levels of adjustment. In each of
the three models, the log 25(OH)D3 was considered as
the dependent variable and either the WC, HC, WHR,
BMI or % TBF was included as a predictor variable. The
fat-free mass (FFM), body weight and absolute TBF were
not tested either because of their limited or somewhatlower explanatory power compared with the other an-
thropometric variables or the % TBF, and therefore were
not expected to provide any additional information.
Model 1 represents each association of the anthropo-
metric and body composition variables with the log 25
(OH)D3 adjusted for age, while model 2 additionally
adjusts for lifestyle factors (PAL, sun exposure, smoking,
use of vitamin D supplements, alcohol consumption,
vitamin D and calcium intake). Model 3 comprises all
covariates of model 2 and additionally considers iPTH as
a confounding variable. Statistical analyses were done
using the SPSS 18.0 statistical package for Windows
(SPSS Inc., Chicago, USA). The significance level was set
at P< 0.05. All tests were two-tailed.
Results
Characteristics of the study subjects
The characteristics of the subjects are presented in Table 1.
None of the subjects had a serious vitamin D deficiency,
but 25.6 % of the women and 19.5 % of the men had 25
(OH)D3 levels< 50 nmol/L. Levels≥ 75 nmol/L were
observed in 18.9 % of the females and 22.0 % of the males.
Adiposity and the prevalence of vitamin D insufficiency
by using two cut-off values
The women with BMIs ≥ 25 kg/m² had a higher preva-
lence of vitamin D insufficiency compared to the
normal-weight women when the cut-off value of
75 nmol/L was applied (69.9 % vs. 30.1 %; P= 0.012), but
not when the lower value of 50 nmol/L was used
(P= 0.132). Men showed no differences regarding the
prevalence of vitamin D insufficiency when stratified
according to BMI, which was independent of the cut-off
value that was used (both P> 0.200). No differences
were found after dividing the cohort into subjects with
abdominal obesity and those without, independent of
sex (all P> 0.200). In women, but not in men, the BMI,
WC and HC were higher in subjects with 25(OH)D3
levels< 50 nmol/L compared to subjects with 25(OH)D3
levels ≥ 50 nmol/L (all P< 0.05). When using the cut-off
value of 75 nmol/L, the % TBF was significantly higher
in both the female and male subjects with 25(OH)D3
levels< 75 nmol/L (both P< 0.05).
Univariate associations between 25-hydroxyvitamin D3
and other parameters
Table 2 provides the results of the univariate linear re-
gression analyses. In women, the log 25(OH)D3 was
associated with body weight, HC, BMI, absolute and %
TBF, alcohol consumption, sun exposure, PAL and
iPTH. In men, sun exposure, PAL and current or past
smoking significantly affected the log 25(OH)D3. All
other parameters, including age, WC, WHR, absolute
FFM and intake of vitamin D, calcium and vitamin D
Table 1 Descriptive characteristics of the study population
Characteristics Women (n=90) Median (P5–P95) Men (n=41) Median (P5–P95) P-value
a)
Age (y) 75.5 (69.0–86.5) 76.0 (70.0–84.8) 0.546
Height (cm) 160.0 (150.5–168.7) 174.5 (161.6–183.5) < 0.0001
Weight (kg) 67.8 (52.9–85.2) 78.5 (63.7–98.0) < 0.0001
Body mass index (kg/m²) 26.3 (20.8–34.5) 26.4 (22.9–32.3) 0.806
Waist circumference (cm) 90.0 (71.6–108.4) 100.0 (84.4–113.8) < 0.0001
Hip circumference (cm) 106.0 (91.6–122.5) 104.0 (95.2–116.8) 0.170
Waist-to-hip ratio 0.85 (0.76–0.93) 0.96 (0.86–1.06) < 0.0001
Fat-free mass (kg) 39.5 (34.5–45.1) 55.3 (48.6–62.6) < 0.0001
Total body fat (kg) 28.1 (17.2–41.6) 24.2 (14.4–36.0) 0.001
Total body fat (%) 41.9 (32.4–50.1) 29.0 (21.5–37.9) < 0.0001
25(OH)D3 (nmol/L) 59.4 (39.9–90.6) 67.5 (39.7–88.9) 0.096
iPTH (pmol/L) 4.5 (2.3–7.9) 4.1 (2.1–8.3) 0.360
Vitamin D intake (μg/d) 2.3 (0.3–10.1) 3.5 (1.0–11.3) 0.078
Calcium intake (g/d) 1.0 (0.5–1.8) 1.0 (0.6–1.6) 0.953
Alcohol intake (g/d) 2.3 (0.0–16.1) 5.1 (0.0–30.0) 0.018
Sun exposure (min/d) 120.0 (40.0–360.0) 150.0 (22.5–396.0) 0.130
Physical activity level 1.7 (1.5–2.0) 1.7 (1.4–1.9) 0.254
Current or ex-smokers, n (%) 20 (22.2) 29 (70.7) < 0.0001
Vitamin D supplement users, n (%) 15 (16.7) 2 (4.9) 0.091
Abbreviations: 25(OH)D3, 25-hydroxyvitamin D3; iPTH, intact parathyroid hormone.
a) Tests of significance between the sexes were based on the Mann-Whitney U test for continuous variables and the χ² test for categorical variables.
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D3. The linear relationships of the log 25(OH)D3 with
HC, BMI and % TBF in women are illustrated in
Figure 1.Adjusted associations of 25-hydroxyvitamin D3 with
anthropometric and body composition variables
The results of the multiple regression analyses with dif-
ferent levels of adjustment are shown in Table 3. Due to
the observed collinearity of the anthropometric and
body composition variables (data not shown), these vari-
ables were added as potential predictor variables in sep-
arate models by replacing each other. No associations
existed between the log 25(OH)D3 and WC or WHR in
either sex. In men, the BMI, HC and % TBF were not
associated with the log 25(OH)D3, independent of the
level of adjustment. In contrast, the % TBF emerged as a
negative predictor for the log 25(OH)D3 in women both
before and after an additional adjustment for iPTH,
whereas the BMI and HC were not significantly asso-
ciated with the log 25(OH)D3 after a full adjustment that
included iPTH. In women, the fully adjusted model 3,
with % TBF as a predictor variable, explained 27.4 % of
the variation in 25(OH)D3 levels and the % TBF
accounted for 4.9 % of the variation in this regard.Besides the % TBF, iPTH (ß=−0.345; P< 0.001) and sun
exposure (ß = 0.239; P= 0.018) were independent deter-
minants of the log 25(OH)D3 in women, while alcohol
intake showed a borderline significant association
(ß= 0.188; P = 0.052). In men, only smoking (ß =−0.438;
P = 0.005) had an independent impact on the log 25
(OH)D3. When we created multiple regression models
including only those variables as confounders that
exhibited a significant association with the log 25(OH)
D3 in the univariate analyses, so that iPTH levels, alco-
hol intake, sun exposure and PAL were included in the
female model and sun exposure, PAL and smoking be-
haviour in the male model, this yielded equal results
(data not shown).Discussion
To our knowledge, this is the first study that examines the
associations of anthropometric and body composition
variables with the vitamin D status of predominantly non-
obese, non-vitamin D-deficient, well-functioning elderly
women and men from Germany while also considering
the potentially confounding effects of age, lifestyle factors
and iPTH.
In contrast to other studies of elderly people [15,23,34],
none of the GISELA subjects had a severe vitamin D
Table 2 Univariate linear regression analyses between
the log-transformed 25-hydroxyvitamin D3 and other
parameters
Characteristics log 25(OH)D3
Women (n=90) Men (n=41)
ß P-value ß P-value
iPTH (pmol/L) −0.379 < 0.001 −0.212 0.182
Age (y) −0.107 0.315 −0.200 0.209
Weight (kg) −0.240 0.023 0.103 0.521
Body mass index (kg/m²) −0.261 0.013 −0.040 0.806
Waist circumference (cm) −0.181 0.088 −0.126 0.434
Hip circumference (cm) −0.235 0.026 −0.039 0.809
Waist-to-hip ratio −0.029 0.789 −0.140 0.382
Fat-free mass (kg) −0.137 0.199 0.268 0.090
Total body fat (kg) −0.261 0.013 −0.012 0.939
Total body fat (%) −0.283 0.007 −0.088 0.584
Vitamin D intake (μg/d) −0.029 0.788 −0.092 0.568
Calcium intake (g/d) −0.049 0.645 −0.015 0.925
Alcohol intake (g/d) 0.211 0.046 0.100 0.533
Sun exposure (min/d) 0.301 0.004 0.370 0.017
Physical activity level 0.212 0.044 0.442 0.004
Current or past smoking a) 0.007 0.946 −0.520 < 0.001
Vitamin D supplement use a) 0.134 0.207 0.172 0.283
Abbreviations: log 25(OH)D3, log-transformed 25-hydroxyvitamin D3;
ß, standardised coefficient; iPTH, intact parathyroid hormone.
a) Dummy variable (no/yes).
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25 % of the subjects had 25(OH)D3 levels< 50 nmol/L,
the prevalence of vitamin D insufficiency in the general
German population aged 65–79 years exceeds 50 %, even
during the summer [34].
Previous studies have reported a higher prevalence of
vitamin D insufficiency in obese subjects compared to
lean individuals [9,35]. In our study, the prevalence ofß = –0.235, P = 0.026 ß 
Figure 1 Association of body composition with the log-transformed 2
serum 25-hydroxyvitamin D3 (25(OH)D3) and the hip circumference (left pa
in women aged 66 to 96 years (n= 90). The P values and the standardisedvitamin D insufficiency was 39.8 % lower in normal-
weight women than in women with BMIs ≥ 25 kg/m²
when using the cut-off value of 75 nmol/L. When our
study cohort was stratified by 25(OH)D3 status, indivi-
duals with an adequate vitamin D status (≥ 75 nmol/L)
had a lower % TBF than subjects with 25(OH)D3
levels< 75 nmol/L. This suggests that a higher % TBF
may have limited the increase in 25(OH)D3 levels over
the threshold of 75 nmol/L or, alternatively, a sufficient
vitamin D status may have protected against an increas-
ing TBF.
At present there is a great debate on the 25(OH)D3 tar-
get thresholds as regards multiple health outcomes and
hence guidelines for dietary intakes. While the Institute of
Medicine (IoM) suggests 50 nmol/L as the target value for
dietary reference intakes of vitamin D [36], others favour
75 nmol/L or even higher values as sufficiency threshold
[30]. We observed distinct differences in the % TBF of
subjects with vitamin D insufficiency only when using
75 nmol/L as cut-off level, whereas anthropometric vari-
ables already differed between subjects with 25(OH)D3
levels≥ 50 nmol/L and those with< 50 nmol/L. As the
multiple regression analyses revealed that the % TBF, but
none of the anthropometric variables, is a key determinant
of 25(OH)D3 levels, this might favour the view that the
threshold of 75 nmol/L reflects a more adequate cut off-
value than 50 nmol/L. However, the observed linear rela-
tionship between % TBF and 25(OH)D3 indicates that a
defined threshold concentration of 25(OH)D3 with regard
to adiposity may not exist in our study population of non-
vitamin D-deficient elderly individuals. Consequently, the
requirements for vitamin D of individuals to achieve or
exceed a defined cut-off level may depend on their % TBF,
which may be highly variable even at a given BMI.
In our univariate analyses, the anthropometric and
body composition variables had an impact on 25(OH)D3
only in women, which may be attributed to the small
sample size of men and to the lower % TBF in men and= –0.261, P = 0.013 ß = –0.283, P = 0.007 
5-hydroxyvitamin D3 in elderly women. Associations between
nel), BMI (middle panel) and percentage of total body fat (right panel)
coefficients ß were calculated by univariate regression analyses.
Table 3 Multiple regression analyses between 25-
hydroxyvitamin D3 and the respective anthropometric or
body composition parameter a)
Women (n=90) Men (n=41)
log 25(OH)D3 log 25(OH)D3
B ß P-value B ß P-value
WC (cm)
Model 1 −0.002 −0.189 0.075 −0.001 −0.146 0.362
Model 2 −0.002 −0.176 0.096 −0.001 −0.097 0.489
Model 3 b) −0.001 −0.155 0.115 −0.001 −0.071 0.632
HC (cm)
Model 1 −0.003 −0.260 0.015 −0.001 −0.043 0.786
Model 2 −0.002 −0.202 0.058 −0.001 −0.042 0.769
Model 3 b) −0.002 −0.141 0.161 −0.0004 −0.026 0.855
WHR
Model 1 −0.035 −0.018 0.869 −0.252 −0.168 0.293
Model 2 −0.137 −0.070 0.522 −0.157 −0.105 0.462
Model 3 b) −0.251 −0.128 0.208 −0.118 −0.079 0.602
BMI (kg/m²)
Model 1 −0.007 −0.285 0.007 −0.003 −0.084 0.608
Model 2 −0.006 −0.240 0.026 −0.002 −0.060 0.678
Model 3 b) −0.005 −0.186 0.065 −0.001 −0.037 0.803
TBF (%)
Model 1 −0.006 −0.315 0.003 −0.002 −0.104 0.517
Model 2 −0.005 −0.284 0.010 −0.001 −0.031 0.827
Model 3 b) −0.005 −0.247 0.016 −0.0003 −0.014 0.920
Abbreviations: WC, waist circumference; HC, hip circumference; WHR, waist-to-
hip ratio; BMI, body mass index; TBF, total body fat.
a) Multiple regression analyses using the log-transformed 25-hydroxyvitamin
D3 as the dependent variable and the respective anthropometric and body
composition parameters as the predictor variables. The results of the
regression analyses are expressed in terms of B (the unstandardised
coefficient), ß (standardised coefficient), and the adjusted coefficient of
determination (R2) for the final model 3. Model 1: association adjusted for age
(y). Model 2: model 1 with additional adjustments for physical activity level,
sun exposure (min/d), vitamin D intake (μg/d), calcium intake (g/d), alcohol
consumption (g/d), smoking (never-smokers vs. current or ex-smokers) and use
of vitamin D supplements (no/yes). Model 3: model 2 controlled for intact
parathyroid hormone (pmol/L).
b) Adjusted coefficient of determination (R2) for the respective model 3
(including the respective anthropometric and body composition variable and
all covariates) for women (WC= 0.243; HC= 0.238; WHR= 0.235; BMI = 0.252;
and % TBF = 0.274) and for men (WC= 0.275; HC= 0.270; WHR = 0.276;
BMI = 0.271; and % TBF = 0.270).
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male subjects. Of the anthropometric and body compos-
ition variables examined in our study, the % TBF was
the strongest predictor of the 25(OH)D3 status in the
women. An inverse association between the concentra-
tion of 25(OH)D and % TBF was also reported in a study
of 410 women aged 20–80 years [8] and in a study of
112 postmenopausal women [18]; however, no associ-
ation of 25(OH)D levels with BMI was found in eitherstudy. In contrast, 25(OH)D levels were negatively
affected by the BMI, but not by the % TBF, in a study of
only overweight and obese middle-aged subjects [37].
Other authors [20] reported an inverse association of 25
(OH)D levels with the % TBF in elderly people, which
was stronger in women and stronger than the associa-
tions of 25(OH)D levels with the anthropometric vari-
ables. Our results support the conclusion that the %
TBF represents a more potent predictor of the 25(OH)
D3 status compared with BMI or other anthropometric
variables.
We did not find a relationship of 25(OH)D3 levels with
the WC or WHR, which does not support the hypoth-
esis that the abdominal fat tissue exerts an important ef-
fect on the vitamin D status, as others have suggested
[12-14,38]. Snijder et al. [20] reported that a greater WC
had a negative impact on 25(OH)D levels in both sexes,
whereas the WHR was not associated with 25(OH)D
levels. Moschonis et al. [18] observed no associations of
25(OH)D levels with either the WC or HC in postmeno-
pausal women. In our study, the negative impact of the
HC on 25(OH)D3 levels indicates a specific role of per-
ipheral or subcutaneous fat tissue, which is in line with
the hypothesis that a low 25(OH)D3 status is a conse-
quence of an increased sequestration of vitamin D in
adipose tissue, especially in the subcutaneous fat [39].
At present, it is unclear whether adipose tissue acts as
a reservoir for vitamin D by releasing vitamin D into the
circulation when required or as a metabolic trap that
reduces its bioavailability [6,39]. Moreover, there is un-
certainty about the causal character of the association
between TBF and 25(OH)D. In this context, it has been
hypothesised that a low 25(OH)D status may contribute
to obesity by promoting secondary hyperparathyroidism
[25,40]. Alternatively, it has been postulated that iPTH
may promote weight gain independent of vitamin D by
possibly promoting lipogenesis and inhibiting lipolysis
[25,40]. We observed an inverse association of 25(OH)
D3 with iPTH in women, as reported by others [7,18,33].
In men, we did not find this association, which may be
due to hormonal differences and the sample size. Al-
though the association between the % TBF and 25(OH)
D3 diminished in our study after adjusting for iPTH, the
association remained statistically significant. Thus, iPTH
does not appear to be responsible for the inverse associ-
ation of the % TBF with 25(OH)D3 in our subjects,
which is in line with previous studies [18,20]. Contrary
to the % TBF, the associations between anthropometric
variables and 25(OH)D3 in women were abolished after
adjusting for iPTH, which may be because the BMI does
not adequately reflect the % TBF. The marginal effect of
iPTH on the association of % TBF with 25(OH)D3 in
our study may possibly due to the relatively high vitamin
D status of our participants.
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contribute to a lower vitamin D status in overweight
individuals, such as decreased sun exposure because of
clothing habits [41] or low exercise levels [42]. We
noticed an association of sun exposure with 25(OH)D3,
which is consistent with the literature [7,15,18], and an
association between PAL and 25(OH)D3 in men, as also
reported in other studies [10,17,19,35]. A low PAL may
increase the TBF, which in turn may decrease the bio-
availability of vitamin D. The physically inactive indivi-
duals also typically spend less time outdoors than the
active individuals, which may lead to a lower cutaneous
vitamin D production. While a positive association be-
tween the PAL and sun exposure was present in both
sexes in our study, a significant association between the
PAL and % TBF was only observed in women (data not
shown). According to the results of the multiple regres-
sion analyses, the amounts of sun exposure and physical
activity appear to not be responsible for the inverse asso-
ciation of the % TBF with 25(OH)D3, as also suggested
by others [12,43]. Moreover, smoking, alcohol or the ha-
bitual intake of vitamin D, calcium or vitamin D supple-
ments could not explain the association between the %
TBF and vitamin D status in our study. Nevertheless, we
noted an unexpected strong and independent negative as-
sociation between smoking and 25(OH)D3 in men. While
some previous studies reported a negative association
[17,44,45], other researchers failed to confirm such a rela-
tionship [8,15]. Another finding of our study is the posi-
tive association between alcohol intake and 25(OH)D3 in
women, which has also been reported by others [17,45].
Neither dietary nor supplemental vitamin D had an im-
pact on 25(OH)D3 in our study, which is in contrast to
some [15,17], but not all [8,11], previous studies. Given
the low vitamin D intake from diet and supplements and
the low percentage of supplement users in our study,
these amounts may have been too low to affect 25(OH)D3
levels in non-vitamin D-deficient subjects.
Finally, we observed no age dependency of 25(OH)D3
levels although dermal vitamin D synthesis declines in
advanced age [46]. It is possible that the age gradient
was too small, but most likely, an age-related impair-
ment of vitamin D synthesis is compensated for by ad-
equate sun exposure in our subjects. This is in line with
the observation that individuals aged≥ 60 years are able
to synthesise enough vitamin D during outdoor activities
and thus show a 25(OH)D status similar to young adults
[19]. However, we found that the association between
the % TBF and 25(OH)D3 seems to strengthen after
adjusting for age.
Our study has several strengths and weaknesses. For
the strengths, this study examined both independently
living elderly women and men without a vitamin D defi-
ciency. A special feature in our approach was theconsideration of age, iPTH and a variety of lifestyle fac-
tors as well as different cut-off levels of 25(OH)D3 that
were used to evaluate the vitamin D status. In addition,
confounding was minimised due to well-defined exclu-
sion criteria. For the weaknesses, the cross-sectional de-
sign limited our ability to establish causal relationships.
Due to the sample size, it is possible that some associa-
tions were classified as not statistically significant be-
cause of a type II error. Nevertheless, we found an
independent and robust association between the % TBF
and 25(OH)D3 levels in women. The subjects in this
study were volunteers, had a higher educational level
and were more aware of health issues than their peers in
the general German population. In general, the study
comparability is limited due to varying study designs
among this and other studies, especially regarding the
period of recruitment, assay methods and differences in
the participants’ ages and BMIs. The use of different 25
(OH)D assays has been a matter of dispute [47]. It is
possible that the ECLIA used in this study has systemat-
ically over- or underestimated the 25(OH)D3 levels of
our subjects. However, the measurement results of the
ECLIA are in a good overall agreement with those deter-
mined by tandem mass spectrometry [48]. Further lim-
itations are the use of self-reported data, the indirect
measurements of sun exposure and physical activity and
missing information on the exact dosage and duration of
the intake of vitamin D supplements. Considering the
seasonal variation of 25(OH)D3 levels, our data may not
clearly reflect the year-long vitamin D status of our par-
ticipants. Finally, while dual-energy X-ray absorpti-
ometry (DXA) may reflect the body composition better
than BIA, our BIA equation has been validated against
the DXA. In general, BIA works well in subjects with a
relatively stable water and electrolyte balance when
using an appropriate and validated BIA equation [49].
Conclusion
In conclusion, the present study provides evidence that,
especially in elderly women, the % TBF can be an im-
portant negative determinant of the 25(OH)D3 status,
which is for the most part independent of age, lifestyle
factors and iPTH. Remarkably, we found this association
during the summer in subjects who were primarily not
obese and not vitamin D-deficient. Consequently, the
requirements for vitamin D to achieve or exceed a
defined cut-off level for 25(OH)D3 may depend on the %
TBF, which may be highly variable even at a given BMI.
Although our results indicate that, besides regular phys-
ical activity, adequate sun exposure and abstinence from
smoking, a reduction in TBF may be one possible strat-
egy to improve the vitamin D status, this may not easily
be achievable or not even appropriate in the elderly.
Therefore, and in view of the high prevalence of
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vitamin D with a variety of chronic age-related diseases,
a clinical implication might be that especially over-
weight, post-menopausal women should be screened for
vitamin D deficiency and, as the case may be, specifically
advised to increase their vitamin D intake either by sup-
plements or vitamin D-enriched foods.
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